Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Dexcom Inc (NQ: DXCM )

77.83 +5.00 (+6.87%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Dexcom Stock Collapses 33% After Sales Miss Leads To $25 Million Guidance Cut
Shares are poised to open Friday at their lowest point since April 2022. 
Via Investor's Business Daily
Topics Earnings
Exposures Financial
Nasdaq 100 Falls To 7-Week Lows, Marks Worst 2-Day Drop In Nearly 2 Years As Tech Rout Rages On
Nasdaq 100 index falls to its lowest level since June amid volatility. Despite a brief boost from Q2 GDP growth and decreasing prices, it dropped 4.7% in 2 sessions. 
Via Benzinga
DexCom Stock Drops After Mixed Q2 Results, Weak Forward Guidance
DexCom shares are dropping after the company reported its second-quarter financial results Thursday. Here's a look at the key figures from the report. 
Via Benzinga
$100 Invested In DexCom 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program
From DexCom, Inc.
Via Business Wire
NASDAQ:DXCM: a strong growth stock preparing for the next leg up?.
DEXCOM INC (NASDAQ:DXCM): a strong growth stock preparing for the next leg up?. 
Via Chartmill
What Analysts Are Saying About DexCom Stock
Via Benzinga
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizing TV and guerilla marketing. CEO Robert Ford expects Lingo to become a... 
Via Benzinga
2 Healthcare Stocks to Buy at a Discount
Beaten-down stocks can sometimes present an opportunity. 
Via The Motley Fool
Top 4 Must-Have Healthcare Stocks for Long-Term Growth
Investing in healthcare offers long-term growth and stability fueled by demographic trends, technological advancements, and rising demand. 
Via MarketBeat
3 Breakthrough Medical Device Stocks to Invest In Now
Uncover the potential of leading medical device stocks boasting solid fundamentals and a promising future ahead. 
Via InvestorPlace
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
Via Benzinga
Why NASDAQ:DXCM Is a Standout High-Growth Stock in a Consolidation Phase.
Why DEXCOM INC (NASDAQ:DXCM) Is a Promising High-Growth Stock in the Midst of Consolidation. 
Via Chartmill
Here's How Much $1000 Invested In DexCom 5 Years Ago Would Be Worth Today
Via Benzinga
Peering Into DexCom's Recent Short Interest
Via Benzinga
2 Top Growth Stocks to Buy With $1,000
These stocks have excellent track records of beating the market. 
Via The Motley Fool
Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034
These millionaire-maker stocks could turn a $50,000 investment into $1 million by 2034 if their growth trajectories remain intact. 
Via InvestorPlace
Hype Hazards: 3 Stocks to Steer Clear of on Your Wealth-Building Journey
Learn why DexCom, TransDigm, and Datadog, three hyped stocks trading at rich valuations, may not be the best additions to your portfolio. 
Via InvestorPlace
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,800 Today
Via Benzinga
Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes
From DexCom, Inc.
Via Business Wire
The 3 Best Diabetes Stocks to Buy in June 2024
There's less fear now about weight-loss drugs reducing the need for diabetes devices. Here are three diabetes stocks to buy. 
Via InvestorPlace
What's New In the Consumer Tech World Last Week? News That You Should Know (June 9-June 15, 2024)
Via Benzinga
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
The FDA clearance for two new CGMs puts Abbott on track to rival Dexcom's new Stelo device. 
Via Investor's Business Daily
Exposures Product Safety
Apple Watch Now Directly Syncs With Dexcom's G7 Glucose Monitor
Dexcom Inc. has enabled direct Apple Watch connectivity for its G7 glucose monitor, allowing users to access real-time glucose data without needing an iPhone. 
Via Benzinga
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
From DexCom, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
From Dexcom, Inc.
Via Business Wire
Bull Market Buys: 2 Growth Stocks to Own for the Long Haul
Innovation is paying off for both of these medical device specialists. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.